HPV Vaccines – Do the Risks Outweigh the Benefits?

SEO Press Release

Bobbi Cowan Public Relations
North Hollywood, CA
Phone: 818-980-2372
Email: bobbicowan@sbcglobal.net


North Hollywood, CA, April 22, 2010 — In the August 2009 issue of JAMA. 2009;302(7):795-796.; Journal of the American Medical Association, Charlotte Haugh, MD, PhD, MCs, posed an interesting question regarding Gardasil® and Cervarix®: “When do physicians know enough about the beneficial effects of a new medical intervention to start recommending or using it? When is the available information about harmful adverse effects sufficient to conclude that the risks outweigh the potential benefits?

Members of TruthaboutGardasil.org believe the risks from HPV vaccines outweigh any benefits. Approximately 18,000 adverse reactions, 67 deaths, and 272 cases of abnormal pap tests up to two years post-vaccination have been reported to the Vaccine Adverse Event Reporting System (VAERS). However, according to the National Vaccine Information Center (NVIC) only 1 to 10 percent of the adverse events are reported.

Why such a low percentage? Adverse reactions and deaths in many cases have not been linked to HPV vaccines, and are noted by physicians as “mystery illnesses.”

Dr. Haugh writes: “Whether a risk is worth taking depends not only on the absolute risk, but on the relationship between the potential risk and the potential benefit. If the potential benefits are substantial, most individuals would be willing to accept the risks. But the net benefit of the HPV vaccine to a woman is uncertain. Even if persistently infected with HPV, a woman most likely will not develop cancer if she is regularly screened. So rationally she should be willing to accept only a small risk of harmful effects from the vaccine.”

The JAMA article states that risks from HPV vaccination include: anaphylaxis, Guillain-Barré syndrome, transverse myelitis, pancreatitis, and venous thromboembolic events. Additional VAERS reports include: nausea, dizziness, epileptic seizures, extreme pain in joints, paralysis, palpitations, tingling, numbness, brain fog, weak legs, loss of vision, hair loss, bloody stools, vomiting blood, hyperpigmented plaques overlying the vessels, degenerative disk disease, loss of peripheral vision, slurred speech, loss of motor movement, enlarged liver, sleep apnea, menstrual cycle disruption, ruptured ovarian cysts, enlarged fallopian tubes, bleeding/enlarged or complex ovarian cyst, migraines, and back pain.

Not one girl, who has been adversely injured by the HPV vaccines, has fully recovered from her illnesses.  According to NVIC Director Barb Loe Fisher, “The biological mechanisms for potential brain/immune system damage caused by Gardasil and Cervarix are likely multi-factoral and related to individual host characteristics; genes, health at time of vaccination, which includes menstrual status; previous vaccine reactions; co-exposure to other environmental toxins; etc.” How can the use of a one-size-fits-all-vaccine be justified based on this?

Dr. Haugh closes her article by stating, “When weighing evidence about risks and benefits, it is also appropriate to ask who takes the risk, and who gets the benefit?”

Members of TruthAboutGardasil.org advocate public health policies mandating that girls and their parents be fully informed about the potential risks, all reported adverse events, and be given the vaccine package insert to read prior to inoculations.



Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.